1 | searching | 1,902 |
2 | blocking | 1,785 |
3 | stimulating | 1,362 |
4 | triggering | 577 |
5 | stabilizing | 556 |
6 | releasing | 483 |
7 | checking | 326 |
8 | relaxing | 162 |
9 | boosting | 158 |
10 | sensitizing | 119 |
11 | hormone-releasing | 117 |
12 | depleting | 90 |
13 | bypassing | 70 |
14 | aggregating | 68 |
15 | dampening | 64 |
16 | stabilising | 54 |
17 | calming | 49 |
18 | dispersing | 46 |
19 | destabilizing | 43 |
20 | sequestering | 40 |
21 | sensitising | 32 |
22 | sterilizing | 31 |
23 | hiding | 27 |
24 | condensing | 25 |
25 | solubilizing | 24 |
26 | gh-releasing | 21 |
27 | nucleating | 21 |
28 | severing | 20 |
29 | cross-checking | 19 |
30 | tranquilizing | 16 |
31 | luteotrophic | 13 |
32 | mobilising | 11 |
33 | constricting | 9 |
34 | knocking-down | 8 |
35 | disassembling | 6 |
36 | permeabilizing | 6 |
37 | unlocking | 6 |
38 | acylating | 5 |
39 | chlorinating | 5 |
40 | agglutinating | 4 |
41 | alkalizing | 4 |
42 | embolizing | 4 |
43 | energizing | 4 |
44 | glycosylating | 4 |
45 | impermeant | 4 |
46 | klinische | 4 |
47 | re-programming | 4 |
48 | re-using | 4 |
49 | -stimulating | 3 |
50 | amberlyst | 3 |
51 | clobenpropit | 3 |
52 | electronmicroscopy | 3 |
53 | gonadotrophs | 3 |
54 | hyperpolarising | 3 |
55 | ionophore-induced | 3 |
56 | reconceptualizing | 3 |
57 | summating | 3 |
58 | thymulin | 3 |
59 | activity-associated | 2 |
60 | agonist-activated | 2 |
61 | anti-hpa-5b | 2 |
62 | betablocking | 2 |
63 | cross-breeding | 2 |
64 | entry-blocking | 2 |
65 | panning | 2 |
66 | photostabilizing | 2 |
67 | stimulation-blocking | 2 |
68 | titering | 2 |
69 | analgesic/adjuvant | 1 |
70 | antagonists-solifenacin | 1 |
71 | cleistogenes | 1 |
72 | dependentwomenhad | 1 |
73 | detemir-specific | 1 |
74 | development.during | 1 |
75 | drug/active | 1 |
76 | forming-granulocyte | 1 |
77 | hcn2-driven | 1 |
78 | hormone/follicle-stimulating | 1 |
79 | hormone–releasing | 1 |
80 | icda-coded | 1 |
81 | inhibition.british | 1 |
82 | inhibitors-and | 1 |
83 | lipid-lowering-hdl-raising | 1 |
84 | m-anticholinergic | 1 |
85 | membrane-stimulating | 1 |
86 | microtubule-disrupting | 1 |
87 | moniotrs | 1 |
88 | nodule-reducing | 1 |
89 | receptor-negative/human | 1 |
90 | receptors-like | 1 |
91 | resistance-improving | 1 |
92 | resistance-reversal | 1 |
93 | searching-related | 1 |
94 | secretion-an | 1 |
95 | sensitising-lowering | 1 |
96 | spme/gc-ms. | 1 |
97 | structurally-distinct | 1 |
98 | sulfourea | 1 |
99 | susceptibility-tested | 1 |
100 | system-acting | 1 |
101 | system-targeting | 1 |
102 | widely-applicable | 1 |
1 | -stimulating | 3 |
2 | activity-associated | 2 |
3 | acylating | 5 |
4 | agglutinating | 4 |
5 | aggregating | 68 |
6 | agonist-activated | 2 |
7 | alkalizing | 4 |
8 | amberlyst | 3 |
9 | analgesic/adjuvant | 1 |
10 | antagonists-solifenacin | 1 |
11 | anti-hpa-5b | 2 |
12 | betablocking | 2 |
13 | blocking | 1,785 |
14 | boosting | 158 |
15 | bypassing | 70 |
16 | calming | 49 |
17 | checking | 326 |
18 | chlorinating | 5 |
19 | cleistogenes | 1 |
20 | clobenpropit | 3 |
21 | condensing | 25 |
22 | constricting | 9 |
23 | cross-breeding | 2 |
24 | cross-checking | 19 |
25 | dampening | 64 |
26 | dependentwomenhad | 1 |
27 | depleting | 90 |
28 | destabilizing | 43 |
29 | detemir-specific | 1 |
30 | development.during | 1 |
31 | disassembling | 6 |
32 | dispersing | 46 |
33 | drug/active | 1 |
34 | electronmicroscopy | 3 |
35 | embolizing | 4 |
36 | energizing | 4 |
37 | entry-blocking | 2 |
38 | forming-granulocyte | 1 |
39 | gh-releasing | 21 |
40 | glycosylating | 4 |
41 | gonadotrophs | 3 |
42 | hcn2-driven | 1 |
43 | hiding | 27 |
44 | hormone-releasing | 117 |
45 | hormone/follicle-stimulating | 1 |
46 | hormone–releasing | 1 |
47 | hyperpolarising | 3 |
48 | icda-coded | 1 |
49 | impermeant | 4 |
50 | inhibition.british | 1 |
51 | inhibitors-and | 1 |
52 | ionophore-induced | 3 |
53 | klinische | 4 |
54 | knocking-down | 8 |
55 | lipid-lowering-hdl-raising | 1 |
56 | luteotrophic | 13 |
57 | m-anticholinergic | 1 |
58 | membrane-stimulating | 1 |
59 | microtubule-disrupting | 1 |
60 | mobilising | 11 |
61 | moniotrs | 1 |
62 | nodule-reducing | 1 |
63 | nucleating | 21 |
64 | panning | 2 |
65 | permeabilizing | 6 |
66 | photostabilizing | 2 |
67 | re-programming | 4 |
68 | re-using | 4 |
69 | receptor-negative/human | 1 |
70 | receptors-like | 1 |
71 | reconceptualizing | 3 |
72 | relaxing | 162 |
73 | releasing | 483 |
74 | resistance-improving | 1 |
75 | resistance-reversal | 1 |
76 | searching | 1,902 |
77 | searching-related | 1 |
78 | secretion-an | 1 |
79 | sensitising | 32 |
80 | sensitising-lowering | 1 |
81 | sensitizing | 119 |
82 | sequestering | 40 |
83 | severing | 20 |
84 | solubilizing | 24 |
85 | spme/gc-ms. | 1 |
86 | stabilising | 54 |
87 | stabilizing | 556 |
88 | sterilizing | 31 |
89 | stimulating | 1,362 |
90 | stimulation-blocking | 2 |
91 | structurally-distinct | 1 |
92 | sulfourea | 1 |
93 | summating | 3 |
94 | susceptibility-tested | 1 |
95 | system-acting | 1 |
96 | system-targeting | 1 |
97 | thymulin | 3 |
98 | titering | 2 |
99 | tranquilizing | 16 |
100 | triggering | 577 |
101 | unlocking | 6 |
102 | widely-applicable | 1 |
1 | spme/gc-ms. | 1 |
2 | sulfourea | 1 |
3 | anti-hpa-5b | 2 |
4 | detemir-specific | 1 |
5 | m-anticholinergic | 1 |
6 | luteotrophic | 13 |
7 | dependentwomenhad | 1 |
8 | ionophore-induced | 3 |
9 | icda-coded | 1 |
10 | activity-associated | 2 |
11 | searching-related | 1 |
12 | agonist-activated | 2 |
13 | susceptibility-tested | 1 |
14 | inhibitors-and | 1 |
15 | klinische | 4 |
16 | receptors-like | 1 |
17 | widely-applicable | 1 |
18 | forming-granulocyte | 1 |
19 | drug/active | 1 |
20 | nodule-reducing | 1 |
21 | cross-breeding | 2 |
22 | hiding | 27 |
23 | searching | 1,902 |
24 | checking | 326 |
25 | cross-checking | 19 |
26 | blocking | 1,785 |
27 | stimulation-blocking | 2 |
28 | entry-blocking | 2 |
29 | betablocking | 2 |
30 | unlocking | 6 |
31 | disassembling | 6 |
32 | calming | 49 |
33 | re-programming | 4 |
34 | dampening | 64 |
35 | panning | 2 |
36 | triggering | 577 |
37 | titering | 2 |
38 | sequestering | 40 |
39 | severing | 20 |
40 | sensitising-lowering | 1 |
41 | development.during | 1 |
42 | releasing | 483 |
43 | hormone-releasing | 117 |
44 | gh-releasing | 21 |
45 | hormone–releasing | 1 |
46 | lipid-lowering-hdl-raising | 1 |
47 | stabilising | 54 |
48 | mobilising | 11 |
49 | hyperpolarising | 3 |
50 | sensitising | 32 |
51 | condensing | 25 |
52 | dispersing | 46 |
53 | bypassing | 70 |
54 | re-using | 4 |
55 | nucleating | 21 |
56 | aggregating | 68 |
57 | stimulating | 1,362 |
58 | -stimulating | 3 |
59 | hormone/follicle-stimulating | 1 |
60 | membrane-stimulating | 1 |
61 | acylating | 5 |
62 | glycosylating | 4 |
63 | summating | 3 |
64 | chlorinating | 5 |
65 | agglutinating | 4 |
66 | system-acting | 1 |
67 | constricting | 9 |
68 | system-targeting | 1 |
69 | depleting | 90 |
70 | microtubule-disrupting | 1 |
71 | boosting | 158 |
72 | resistance-improving | 1 |
73 | relaxing | 162 |
74 | energizing | 4 |
75 | alkalizing | 4 |
76 | reconceptualizing | 3 |
77 | permeabilizing | 6 |
78 | stabilizing | 556 |
79 | destabilizing | 43 |
80 | photostabilizing | 2 |
81 | solubilizing | 24 |
82 | sterilizing | 31 |
83 | tranquilizing | 16 |
84 | embolizing | 4 |
85 | sensitizing | 119 |
86 | inhibition.british | 1 |
87 | resistance-reversal | 1 |
88 | secretion-an | 1 |
89 | receptor-negative/human | 1 |
90 | hcn2-driven | 1 |
91 | antagonists-solifenacin | 1 |
92 | thymulin | 3 |
93 | knocking-down | 8 |
94 | cleistogenes | 1 |
95 | gonadotrophs | 3 |
96 | moniotrs | 1 |
97 | structurally-distinct | 1 |
98 | clobenpropit | 3 |
99 | impermeant | 4 |
100 | analgesic/adjuvant | 1 |
101 | amberlyst | 3 |
102 | electronmicroscopy | 3 |